Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 1 (2004), Issue 2 (September)

1. Smoking is associated with postmenopausal breast cancer in women with high levels of estrogens.
   Int J Cancer, 112(2): 324-8. [Abstract] [Full-text]
2. Endogenous sex hormones and subsequent breast cancer in premenopausal women.
   Int J Cancer, 112(2): 312-8. [Abstract] [Full-text]
3. First pregnancy characteristics and subsequent breast cancer risk among young women.
   Int J Cancer, 112(2): 306-11. [Abstract] [Full-text]
4. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
   Int J Cancer, 112(2): 286-94. [Abstract] [Full-text]
5. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.
   Int J Cancer, 112(2): 231-8. [Abstract] [Full-text]
6. Diurnal cortisol rhythm and fatigue in breast cancer survivors.
   Psychoneuroendocrinology, 30(1): 92-100. [Abstract] [Full-text]
7. Antiproliferative effect of butyltin in MCF-7 cells.
   Environ Res, 96(3): 305-10. [Abstract] [Full-text]
8. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
   Cancer Lett, 214(2): 243-51. [Abstract] [Full-text]
9. A breast cancer fear scale: psychometric development.
   J Health Psychol, 9(6): 753-62. [Abstract] [Full-text]
10. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
    Biomaterials, 26(9): 979-86. [Abstract] [Full-text]
11. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
    Cancer Lett, 215(1): 101-12. [Abstract] [Full-text]
12. Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice.
    Cancer Lett, 215(1): 95-100. [Abstract] [Full-text]
13. Frequent mutations in the mitochondrial control region DNA in breast tissue.
    Cancer Lett, 215(1): 89-94. [Abstract] [Full-text]
14. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
    Cancer Lett, 215(1): 83-7. [Abstract] [Full-text]
15. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells.
    Int J Cancer, 112(3): 492-501. [Abstract] [Full-text]
16. Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA.
    Int J Cancer, 112(3): 484-91. [Abstract] [Full-text]
17. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin.
    Int J Cancer, 112(3): 475-83. [Abstract] [Full-text]
18. A novel DNA methyltransferase I-derived peptide eluted from soluble HLA-A*0201 induces peptide-specific, tumor-directed cytotoxic T cells.
    Int J Cancer, 112(3): 426-32. [Abstract] [Full-text]
19. Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.
    Int J Cancer, 112(3): 411-9. [Abstract] [Full-text]
20. PTEN promoter is methylated in a proportion of invasive breast cancers.
    Int J Cancer, 112(3): 407-10. [Abstract] [Full-text]
21. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
    Int J Cancer, 112(3): 399-406. [Abstract] [Full-text]
22. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
    Int J Cancer, 112(3): 357-64. [Abstract] [Full-text]
23. An investigation of mammographic density and gene variants in healthy women.
    Int J Cancer, 112(4): 683-8. [Abstract] [Full-text]
24. Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2.
    Int J Cancer, 112(4): 661-8. [Abstract] [Full-text]
25. Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio.
    Int J Cancer, 112(4): 647-52. [Abstract] [Full-text]
26. Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors.
    Int J Cancer, 112(4): 636. [Abstract] [Full-text]
27. Breast cancer in elderly women.
    Arch Gerontol Geriatr, 39(3): 291-9. [Abstract] [Full-text]
28. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
    Toxicology, 204(2): 197-202. [Abstract] [Full-text]
29. Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
    Cancer Immunol Immunother, 53(11): 1027-40. [Abstract] [Full-text]
30. Pharmacological activity of DTPA linked to protein-based drug carrier systems.
    Biochem Biophys Res Commun, 323(4): 1236-40. [Abstract] [Full-text]
31. Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.
    Biochem Biophys Res Commun, 323(4): 1216-22. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.